BAVENCIO

AVELUMAB · EMD Serono, Inc.

Drug timelines are a Plus or Pro feature.

46 regulatory and trial events tracked for BAVENCIO, covering 2017-03-23 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley) [Phase 2]

See pricing